These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26935935)

  • 1. Primary biliary cirrhosis associated with Graves' disease in a male patient.
    Suzuki Y; Ishida K; Takahashi H; Koeda N; Kakisaka K; Miyamoto Y; Suzuki A; Takikawa Y
    Clin J Gastroenterol; 2016 Apr; 9(2):99-103. PubMed ID: 26935935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient with primary biliary cirrhosis accompanied by Graves disease and Hurthle cell adenoma.
    Yaşar DG; Ozenirler S; Doğan M
    Turk J Gastroenterol; 2007 Sep; 18(3):198-200. PubMed ID: 17891696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Primary Biliary Cirrhosis-autoimmune Hepatitis Overlap Syndrome with Immune Thrombocytopenia and Graves' Disease.
    Koyamada R; Higuchi T; Kitada A; Nakagawa T; Ikeya T; Okada S; Fujita Y
    Intern Med; 2015; 54(16):2013-6. PubMed ID: 26278293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of autoimmune hepatitis in primary biliary cirrhosis.
    Gossard AA; Lindor KD
    Liver Int; 2007 Oct; 27(8):1086-90. PubMed ID: 17845536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status of Liver Transplantation for Primary Biliary Cholangitis.
    Aguilar MT; Carey EJ
    Clin Liver Dis; 2018 Aug; 22(3):613-624. PubMed ID: 30259857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of primary biliary cirrhosis: from diagnosis to end-stage disease.
    Lazaridis KN; Lindor KD
    Curr Gastroenterol Rep; 2000 Apr; 2(2):94-8. PubMed ID: 10981009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of primary biliary cirrhosis.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary biliary cirrhosis: therapeutic advances.
    Czul F; Peyton A; Levy C
    Clin Liver Dis; 2013 May; 17(2):229-42. PubMed ID: 23540499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
    Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
    J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
    Boberg KM; Schrumpf E
    Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic fatigue should not be overlooked in primary biliary cholangitis.
    Shahini E; Ahmed F
    J Hepatol; 2021 Sep; 75(3):744-745. PubMed ID: 33640400
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary biliary cirrhosis (PBC)].
    Rautiainen H
    Duodecim; 2012; 128(15):1550-9. PubMed ID: 22970606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
    Zeng Z; Han YK; Zhang XF; Geng H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):3-5. PubMed ID: 15670480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary biliary cholangitis associated with warm autoimmune hemolytic anemia.
    Gonzalez-Moreno EI; Martinez-Cabriales SA; Cruz-Moreno MA; Borjas-Almaguer OD; Cortez-Hernandez CA; Bosques-Padilla FJ; Garza AA; Gonzalez-Gonzalez JA; Garcia-Compean D; Ocampo-Candiani J; Maldonado-Garza HJ
    J Dig Dis; 2016 Feb; 17(2):128-31. PubMed ID: 26630456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary biliary cirrhosis: therapeutic options].
    Abenavoli L
    Recenti Prog Med; 2009 Sep; 100(9):417-23. PubMed ID: 19886235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.